qingfeng pharmaceutical's class 1 innovative drug gp681 tablets made significant progress -pg麻将胡了模拟器1938
issuing time:2020-09-17 11:10 on august 25, 2020, our clinical research team held a gp681 clinical study kick-off meeting in shanghai xuhui district central hospital, marking that our innovative drug gp681 has officially entered the phase i clinical study.
prev
next
article classification:
|
